Global Adjuvanted Influenza Vaccine Supply, Demand and Key Producers, 2023-2029
The global Adjuvanted Influenza Vaccine market size is expected to reach $ 2117.4 million by 2029, rising at a market growth of 11.6% CAGR during the forecast period (2023-2029).
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
An adjuvanted influenza vaccine is a type of influenza vaccine that has a substance called an 'adjuvant' added during the vaccine preparation process. Adjuvant is a substance that can enhance the immune response. It can improve the response of the immune system to vaccine components (such as viral antigens) after vaccination, thereby increasing the effect of immune protection.
This report studies the global Adjuvanted Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adjuvanted Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adjuvanted Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adjuvanted Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Adjuvanted Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Adjuvanted Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adjuvanted Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Adjuvanted Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adjuvanted Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adjuvanted Influenza Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adjuvanted Influenza Vaccine Market, By Region:
1. How big is the global Adjuvanted Influenza Vaccine market?
2. What is the demand of the global Adjuvanted Influenza Vaccine market?
3. What is the year over year growth of the global Adjuvanted Influenza Vaccine market?
4. What is the production and production value of the global Adjuvanted Influenza Vaccine market?
5. Who are the key producers in the global Adjuvanted Influenza Vaccine market?
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
An adjuvanted influenza vaccine is a type of influenza vaccine that has a substance called an 'adjuvant' added during the vaccine preparation process. Adjuvant is a substance that can enhance the immune response. It can improve the response of the immune system to vaccine components (such as viral antigens) after vaccination, thereby increasing the effect of immune protection.
This report studies the global Adjuvanted Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adjuvanted Influenza Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adjuvanted Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adjuvanted Influenza Vaccine total production and demand, 2018-2029, (K Units)
Global Adjuvanted Influenza Vaccine total production value, 2018-2029, (USD Million)
Global Adjuvanted Influenza Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adjuvanted Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Adjuvanted Influenza Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adjuvanted Influenza Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adjuvanted Influenza Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adjuvanted Influenza Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adjuvanted Influenza Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vial
- Prefilled
- Public Sector
- Private Sector
- CSL
1. How big is the global Adjuvanted Influenza Vaccine market?
2. What is the demand of the global Adjuvanted Influenza Vaccine market?
3. What is the year over year growth of the global Adjuvanted Influenza Vaccine market?
4. What is the production and production value of the global Adjuvanted Influenza Vaccine market?
5. Who are the key producers in the global Adjuvanted Influenza Vaccine market?
1 SUPPLY SUMMARY
1.1 Adjuvanted Influenza Vaccine Introduction
1.2 World Adjuvanted Influenza Vaccine Supply & Forecast
1.2.1 World Adjuvanted Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Adjuvanted Influenza Vaccine Production (2018-2029)
1.2.3 World Adjuvanted Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Adjuvanted Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Adjuvanted Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Adjuvanted Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Adjuvanted Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Adjuvanted Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adjuvanted Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adjuvanted Influenza Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Adjuvanted Influenza Vaccine Demand (2018-2029)
2.2 World Adjuvanted Influenza Vaccine Consumption by Region
2.2.1 World Adjuvanted Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Adjuvanted Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.4 China Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.5 Europe Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.6 Japan Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.9 India Adjuvanted Influenza Vaccine Consumption (2018-2029)
3 WORLD ADJUVANTED INFLUENZA VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adjuvanted Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Adjuvanted Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Adjuvanted Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Adjuvanted Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adjuvanted Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adjuvanted Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Adjuvanted Influenza Vaccine in 2022
3.6 Adjuvanted Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Adjuvanted Influenza Vaccine Market: Region Footprint
3.6.2 Adjuvanted Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Adjuvanted Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adjuvanted Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Adjuvanted Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adjuvanted Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adjuvanted Influenza Vaccine Production Comparison
4.2.1 United States VS China: Adjuvanted Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adjuvanted Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adjuvanted Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Adjuvanted Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adjuvanted Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adjuvanted Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
4.5 China Based Adjuvanted Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Adjuvanted Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adjuvanted Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vial
5.2.2 Prefilled
5.3 Market Segment by Type
5.3.1 World Adjuvanted Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Adjuvanted Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Adjuvanted Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adjuvanted Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public Sector
6.2.2 Private Sector
6.3 Market Segment by Application
6.3.1 World Adjuvanted Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Adjuvanted Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Adjuvanted Influenza Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CSL
7.1.1 CSL Details
7.1.2 CSL Major Business
7.1.3 CSL Adjuvanted Influenza Vaccine Product and Services
7.1.4 CSL Adjuvanted Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CSL Recent Developments/Updates
7.1.6 CSL Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adjuvanted Influenza Vaccine Industry Chain
8.2 Adjuvanted Influenza Vaccine Upstream Analysis
8.2.1 Adjuvanted Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Adjuvanted Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adjuvanted Influenza Vaccine Production Mode
8.6 Adjuvanted Influenza Vaccine Procurement Model
8.7 Adjuvanted Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Adjuvanted Influenza Vaccine Sales Model
8.7.2 Adjuvanted Influenza Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Adjuvanted Influenza Vaccine Introduction
1.2 World Adjuvanted Influenza Vaccine Supply & Forecast
1.2.1 World Adjuvanted Influenza Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Adjuvanted Influenza Vaccine Production (2018-2029)
1.2.3 World Adjuvanted Influenza Vaccine Pricing Trends (2018-2029)
1.3 World Adjuvanted Influenza Vaccine Production by Region (Based on Production Site)
1.3.1 World Adjuvanted Influenza Vaccine Production Value by Region (2018-2029)
1.3.2 World Adjuvanted Influenza Vaccine Production by Region (2018-2029)
1.3.3 World Adjuvanted Influenza Vaccine Average Price by Region (2018-2029)
1.3.4 North America Adjuvanted Influenza Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adjuvanted Influenza Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adjuvanted Influenza Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Adjuvanted Influenza Vaccine Demand (2018-2029)
2.2 World Adjuvanted Influenza Vaccine Consumption by Region
2.2.1 World Adjuvanted Influenza Vaccine Consumption by Region (2018-2023)
2.2.2 World Adjuvanted Influenza Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.4 China Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.5 Europe Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.6 Japan Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.7 South Korea Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.8 ASEAN Adjuvanted Influenza Vaccine Consumption (2018-2029)
2.9 India Adjuvanted Influenza Vaccine Consumption (2018-2029)
3 WORLD ADJUVANTED INFLUENZA VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adjuvanted Influenza Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Adjuvanted Influenza Vaccine Production by Manufacturer (2018-2023)
3.3 World Adjuvanted Influenza Vaccine Average Price by Manufacturer (2018-2023)
3.4 Adjuvanted Influenza Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adjuvanted Influenza Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adjuvanted Influenza Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Adjuvanted Influenza Vaccine in 2022
3.6 Adjuvanted Influenza Vaccine Market: Overall Company Footprint Analysis
3.6.1 Adjuvanted Influenza Vaccine Market: Region Footprint
3.6.2 Adjuvanted Influenza Vaccine Market: Company Product Type Footprint
3.6.3 Adjuvanted Influenza Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adjuvanted Influenza Vaccine Production Value Comparison
4.1.1 United States VS China: Adjuvanted Influenza Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adjuvanted Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adjuvanted Influenza Vaccine Production Comparison
4.2.1 United States VS China: Adjuvanted Influenza Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adjuvanted Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adjuvanted Influenza Vaccine Consumption Comparison
4.3.1 United States VS China: Adjuvanted Influenza Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adjuvanted Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adjuvanted Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
4.5 China Based Adjuvanted Influenza Vaccine Manufacturers and Market Share
4.5.1 China Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
4.6 Rest of World Based Adjuvanted Influenza Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adjuvanted Influenza Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vial
5.2.2 Prefilled
5.3 Market Segment by Type
5.3.1 World Adjuvanted Influenza Vaccine Production by Type (2018-2029)
5.3.2 World Adjuvanted Influenza Vaccine Production Value by Type (2018-2029)
5.3.3 World Adjuvanted Influenza Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adjuvanted Influenza Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Public Sector
6.2.2 Private Sector
6.3 Market Segment by Application
6.3.1 World Adjuvanted Influenza Vaccine Production by Application (2018-2029)
6.3.2 World Adjuvanted Influenza Vaccine Production Value by Application (2018-2029)
6.3.3 World Adjuvanted Influenza Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 CSL
7.1.1 CSL Details
7.1.2 CSL Major Business
7.1.3 CSL Adjuvanted Influenza Vaccine Product and Services
7.1.4 CSL Adjuvanted Influenza Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CSL Recent Developments/Updates
7.1.6 CSL Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adjuvanted Influenza Vaccine Industry Chain
8.2 Adjuvanted Influenza Vaccine Upstream Analysis
8.2.1 Adjuvanted Influenza Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Adjuvanted Influenza Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adjuvanted Influenza Vaccine Production Mode
8.6 Adjuvanted Influenza Vaccine Procurement Model
8.7 Adjuvanted Influenza Vaccine Industry Sales Model and Sales Channels
8.7.1 Adjuvanted Influenza Vaccine Sales Model
8.7.2 Adjuvanted Influenza Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Adjuvanted Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adjuvanted Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adjuvanted Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Adjuvanted Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Adjuvanted Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Adjuvanted Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Adjuvanted Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Adjuvanted Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adjuvanted Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adjuvanted Influenza Vaccine Major Market Trends
Table 13. World Adjuvanted Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adjuvanted Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Adjuvanted Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adjuvanted Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adjuvanted Influenza Vaccine Producers in 2022
Table 18. World Adjuvanted Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adjuvanted Influenza Vaccine Producers in 2022
Table 20. World Adjuvanted Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adjuvanted Influenza Vaccine Company Evaluation Quadrant
Table 22. World Adjuvanted Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adjuvanted Influenza Vaccine Production Site of Key Manufacturer
Table 24. Adjuvanted Influenza Vaccine Market: Company Product Type Footprint
Table 25. Adjuvanted Influenza Vaccine Market: Company Product Application Footprint
Table 26. Adjuvanted Influenza Vaccine Competitive Factors
Table 27. Adjuvanted Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Adjuvanted Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Adjuvanted Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adjuvanted Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adjuvanted Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Adjuvanted Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adjuvanted Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Adjuvanted Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Adjuvanted Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adjuvanted Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adjuvanted Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adjuvanted Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adjuvanted Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adjuvanted Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Adjuvanted Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Adjuvanted Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adjuvanted Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adjuvanted Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adjuvanted Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CSL Basic Information, Manufacturing Base and Competitors
Table 62. CSL Major Business
Table 63. CSL Adjuvanted Influenza Vaccine Product and Services
Table 64. CSL Adjuvanted Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Global Key Players of Adjuvanted Influenza Vaccine Upstream (Raw Materials)
Table 66. Adjuvanted Influenza Vaccine Typical Customers
Table 67. Adjuvanted Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Adjuvanted Influenza Vaccine Picture
Figure 2. World Adjuvanted Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adjuvanted Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adjuvanted Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Adjuvanted Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Adjuvanted Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Adjuvanted Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Adjuvanted Influenza Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 12. World Adjuvanted Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 13. United States Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 14. China Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. Europe Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 16. Japan Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. South Korea Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. ASEAN Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. India Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. Producer Shipments of Adjuvanted Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 21. Global Four-firm Concentration Ratios (CR4) for Adjuvanted Influenza Vaccine Markets in 2022
Figure 22. Global Four-firm Concentration Ratios (CR8) for Adjuvanted Influenza Vaccine Markets in 2022
Figure 23. United States VS China: Adjuvanted Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 24. United States VS China: Adjuvanted Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 25. United States VS China: Adjuvanted Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 26. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 27. China Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 28. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 29. World Adjuvanted Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Adjuvanted Influenza Vaccine Production Value Market Share by Type in 2022
Figure 31. Vial
Figure 32. Prefilled
Figure 33. World Adjuvanted Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 34. World Adjuvanted Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 35. World Adjuvanted Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. World Adjuvanted Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Adjuvanted Influenza Vaccine Production Value Market Share by Application in 2022
Figure 38. Public Sector
Figure 39. Private Sector
Figure 40. World Adjuvanted Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 41. World Adjuvanted Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 42. World Adjuvanted Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 43. Adjuvanted Influenza Vaccine Industry Chain
Figure 44. Adjuvanted Influenza Vaccine Procurement Model
Figure 45. Adjuvanted Influenza Vaccine Sales Model
Figure 46. Adjuvanted Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 47. Methodology
Figure 48. Research Process and Data Source
Table 1. World Adjuvanted Influenza Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adjuvanted Influenza Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adjuvanted Influenza Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Adjuvanted Influenza Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Adjuvanted Influenza Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Adjuvanted Influenza Vaccine Production Market Share by Region (2018-2023)
Table 9. World Adjuvanted Influenza Vaccine Production Market Share by Region (2024-2029)
Table 10. World Adjuvanted Influenza Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adjuvanted Influenza Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adjuvanted Influenza Vaccine Major Market Trends
Table 13. World Adjuvanted Influenza Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adjuvanted Influenza Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Adjuvanted Influenza Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adjuvanted Influenza Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adjuvanted Influenza Vaccine Producers in 2022
Table 18. World Adjuvanted Influenza Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adjuvanted Influenza Vaccine Producers in 2022
Table 20. World Adjuvanted Influenza Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adjuvanted Influenza Vaccine Company Evaluation Quadrant
Table 22. World Adjuvanted Influenza Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adjuvanted Influenza Vaccine Production Site of Key Manufacturer
Table 24. Adjuvanted Influenza Vaccine Market: Company Product Type Footprint
Table 25. Adjuvanted Influenza Vaccine Market: Company Product Application Footprint
Table 26. Adjuvanted Influenza Vaccine Competitive Factors
Table 27. Adjuvanted Influenza Vaccine New Entrant and Capacity Expansion Plans
Table 28. Adjuvanted Influenza Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Adjuvanted Influenza Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adjuvanted Influenza Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adjuvanted Influenza Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 37. China Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Adjuvanted Influenza Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share (2018-2023)
Table 47. World Adjuvanted Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adjuvanted Influenza Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Adjuvanted Influenza Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Adjuvanted Influenza Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adjuvanted Influenza Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adjuvanted Influenza Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adjuvanted Influenza Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adjuvanted Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adjuvanted Influenza Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Adjuvanted Influenza Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Adjuvanted Influenza Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adjuvanted Influenza Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adjuvanted Influenza Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adjuvanted Influenza Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CSL Basic Information, Manufacturing Base and Competitors
Table 62. CSL Major Business
Table 63. CSL Adjuvanted Influenza Vaccine Product and Services
Table 64. CSL Adjuvanted Influenza Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Global Key Players of Adjuvanted Influenza Vaccine Upstream (Raw Materials)
Table 66. Adjuvanted Influenza Vaccine Typical Customers
Table 67. Adjuvanted Influenza Vaccine Typical Distributors
List of Figure
Figure 1. Adjuvanted Influenza Vaccine Picture
Figure 2. World Adjuvanted Influenza Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adjuvanted Influenza Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adjuvanted Influenza Vaccine Production (2018-2029) & (K Units)
Figure 5. World Adjuvanted Influenza Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adjuvanted Influenza Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Adjuvanted Influenza Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Adjuvanted Influenza Vaccine Production (2018-2029) & (K Units)
Figure 9. Adjuvanted Influenza Vaccine Market Drivers
Figure 10. Factors Affecting Demand
Figure 11. World Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 12. World Adjuvanted Influenza Vaccine Consumption Market Share by Region (2018-2029)
Figure 13. United States Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 14. China Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 15. Europe Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 16. Japan Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 17. South Korea Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 18. ASEAN Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 19. India Adjuvanted Influenza Vaccine Consumption (2018-2029) & (K Units)
Figure 20. Producer Shipments of Adjuvanted Influenza Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 21. Global Four-firm Concentration Ratios (CR4) for Adjuvanted Influenza Vaccine Markets in 2022
Figure 22. Global Four-firm Concentration Ratios (CR8) for Adjuvanted Influenza Vaccine Markets in 2022
Figure 23. United States VS China: Adjuvanted Influenza Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 24. United States VS China: Adjuvanted Influenza Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 25. United States VS China: Adjuvanted Influenza Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 26. United States Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 27. China Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 28. Rest of World Based Manufacturers Adjuvanted Influenza Vaccine Production Market Share 2022
Figure 29. World Adjuvanted Influenza Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Adjuvanted Influenza Vaccine Production Value Market Share by Type in 2022
Figure 31. Vial
Figure 32. Prefilled
Figure 33. World Adjuvanted Influenza Vaccine Production Market Share by Type (2018-2029)
Figure 34. World Adjuvanted Influenza Vaccine Production Value Market Share by Type (2018-2029)
Figure 35. World Adjuvanted Influenza Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 36. World Adjuvanted Influenza Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Adjuvanted Influenza Vaccine Production Value Market Share by Application in 2022
Figure 38. Public Sector
Figure 39. Private Sector
Figure 40. World Adjuvanted Influenza Vaccine Production Market Share by Application (2018-2029)
Figure 41. World Adjuvanted Influenza Vaccine Production Value Market Share by Application (2018-2029)
Figure 42. World Adjuvanted Influenza Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 43. Adjuvanted Influenza Vaccine Industry Chain
Figure 44. Adjuvanted Influenza Vaccine Procurement Model
Figure 45. Adjuvanted Influenza Vaccine Sales Model
Figure 46. Adjuvanted Influenza Vaccine Sales Channels, Direct Sales, and Distribution
Figure 47. Methodology
Figure 48. Research Process and Data Source
